HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Himmelfarb Selected Research

IC 486068

7/2004A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Himmelfarb Research Topics

Disease

2Neoplasms (Cancer)
07/2004 - 07/2003
1Liver Cell Adenoma (Hepatocellular Adenoma)
06/2014
1Hepatocellular Carcinoma (Hepatoma)
06/2014
1Focal Nodular Hyperplasia
06/2014
1Adenocarcinoma
12/2010
1Septic Shock (Toxic Shock Syndrome)
05/2010

Drug/Important Bio-Agent (IBA)

1ClusterinIBA
06/2014
1Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2014
1Proteins (Proteins, Gene)FDA Link
12/2010
1ElementsIBA
05/2010
1Panton-Valentine leukocidinIBA
05/2010
15'-N-methylcarboxamideadenosineIBA
05/2010
1staphylococcal enterotoxin BIBA
05/2010
1IC 486068IBA
07/2004
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2004
1Sunitinib (Sutent)FDA Link
07/2003
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2003
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2003
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2003

Therapy/Procedure

2Therapeutics
12/2010 - 07/2003
2Radiotherapy
07/2004 - 07/2003